Related Experiment Video

Updated: Jan 20, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

Triple-negative breast cancer: recent treatment advances

Alice R T Bergin1, Sherene Loi1,2

  • 1Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

F1000Research
|August 27, 2019
PubMed

Insights

Triple-negative breast cancer (TNBC) remains challenging, especially in its metastatic form. Recent advances in poly (ADP-ribose) polymerase (PARP) inhibitors and immunotherapy offer new hope for improving outcomes.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Triple-negative breast cancer (TNBC) disproportionately affects younger women.
  • TNBC is characterized by early metastasis and poor prognosis despite standard treatments.
  • Current treatment focuses on neoadjuvant therapy to improve pathological complete response.

Purpose of the Study:

  • To review recent advances in the treatment of metastatic triple-negative breast cancer.
  • To highlight the impact of novel systemic therapies on patient outcomes.
  • To discuss the role of immunotherapy and PARP inhibitors in TNBC management.

Main Methods:

  • Review of recently published clinical trial data and treatment guidelines.
  • Analysis of outcomes for patients receiving novel combination therapies.
  • Focus on advancements in neoadjuvant, adjuvant, and metastatic settings.

Main Results:

  • Innovative multi-drug combinations have significantly improved outcomes over the last decade.
  • Poly (ADP-ribose) polymerase (PARP) inhibitors and immunotherapy agents show promising results in metastatic TNBC.
  • Immunotherapy combined with chemotherapy alters the natural history of TNBC, particularly in PD-L1 positive tumors.

Conclusions:

  • Despite challenges, significant progress has been made in treating TNBC.
  • Emerging therapies like PARP inhibitors and immunotherapy represent a paradigm shift.
  • Personalized treatment strategies, especially for PD-L1 positive TNBC, are crucial for improving survival.
Keywords:
ImmunotherapyTriple negative breast cancer

More Related Videos

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.6K
A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

1.1K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Scalar and Vector Triple Products01:06

Scalar and Vector Triple Products

Two vectors can be multiplied using a scalar product or a vector product. The resultant of a scalar product is scalar, while with vector products, the resultant is a vector. These rules of the scalar or vector product between two vectors can be applied to multiple vectors to obtain meaningful combinations. The scalar triple product is the dot product of a vector with the cross product of two vectors.
The scalar triple product is the dot product of a vector with the cross product of two vectors....
4.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
Positive, Negative, and Zero Work00:58

Positive, Negative, and Zero Work

Work is done on an object when energy is transferred to the object. In other words, work is done when a force acts on a body that undergoes a displacement from one position to another. By definition, the work done by a force is the integral of the force with respect to the displacement along its path. Forces can vary as a function of position, and displacements can occur along various paths between two points. The magnitude of a force multiplied by the cosine of the angle that the force makes...
22.0K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
485